1.A novel anticancer natural product SP09 selectively targets KRAS-mutant NSCLC through LKB1/AMPK/mTOR modulation: implications for novel therapeutic development
Peng Yue, Chitin Hon More...
Peng Yue, Chitin Hon, Xiaoping Zhao, Fayaz Ali, Jiayi Sun, Jiyou Ko Less
Anti-cancer Drugs[0959-4973], Published 2025,
2024影響因子: 2.2
本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器
Copyright © 2018 澳門科技大學學者庫